Technologies for Licensing
McGill University has a rich history of scholarship and strong tradition of cutting edge research and innovation. McGill strives to translate the outcomes of its research endeavors in ways that have regional, national and global impact. McGill University maintains a comprehensive intellectual property portfolio.
You can view a selection of technologies that are available for licensing below:
Agriculture
Plant Variety
Biomedical
Biomarkers
Specific biomarkers for various parasitic infections (04028)
The CUX1 Expression Signature (C1S) As a Predictor of Breast Cancer outcome (10081)
SDPP: Breast cancer prognostic test (07033)
Prognostic test for treatment of diffuse large B-cell lymphoma (05041)
Genetic Marker for Recurrent Abortions (11071)
Diagnostics and Instrumentation
Ultrasound System and methods for quantifying analytes and point of care diagnostics (06080)
Ultrasound System for measuring pH and point of care parameters (09077)
Rapid Malaria Detection (07116)
Automatic identification and classification of Vestibulo-Ocular Responses (11045)
Polymeric Systems for Signal Amplification in Gene Detection (05094)
Universal electronic microfluidic systems (07037)
Microfluidic microarray for multiplex analysis of biomolecules (07084)
Devices
Portable System for Treatment for Amblyopia (10095)
New Medical Device to predict postoperative nausea and vomiting (PONV) syndrome (06100)
Portable Uroflow meter (04048)
Cariology Probe For Dental Examination (09104)
Hybrid Silicon Neural Microelectrode (09083)
Surgical
Porous Compression Screw for Bone Fixation (08091)
An expandable prosthetic vertebral system (07060)
An expandable spacer for replacing vertebrae using minimally invasive posterior surgery (11093)
Innovative wrist arthroplasty system (08004)
Electrochemical process to chemically functionalize metal surfaces (10063)
Clean Tech
Chemicals and Chemical Processes
Imidazolium Type Ionic Oligomers (07054)
Effective Low Cost Water Purification System (11070)
New polymers with high glass transition temperture (11091)
A nano-composite catalyst: Pd nanoparticles deposited onto Cellulose nanocrystallites (12013)
Energy
Green and Cost-Effective TiO2 Paste for Dye-Sensitized Solar Cells (11078)
Dot-in-a-wire light emiting diodes (11061)
Semiconducting Group III-Nitride Nanowires for Photochemical Splitting of Water to generate Hydrogen (11030)
Environment
Mechanical and Materials
Network Communications
Research Tools
Animal Models
Transgenic rat model of Alzheimer’s disease (06063)
Murine Model to validate Drug Candidates against Asthma and Allergic Rhinitis (P100)
Gene knockout model to validate drug candidates for Cystic Fibrosis (P101)
Antibodies
Cell Lines
Other Research Tools
Software
Thereapeutic Agents
Biologicals
Cell Permeable Peptide for Treatment of Allergic Airway Diseases (05003)
Anti-Mitotic peptides for the treatment of cancer (04086)
Soluble IGF-1 Receptor for Cancer and Metastasis (09120)
GIFT-21: a fusokine for targeted cancer immunotherapy (09051)
GIFT15: an immunosuppressant for parenteral administration or ex-vivo use (06087)
Netrin Derivatives for inhibiting metastasis and neovascularization (10006)
A chemistry platform for gene silencing: FANA antisense oligonucleotide construct (97032)
Nucleic acid hairpins as inhibitors of HIV RNAse H (03050)
Peptide and protein wound healing agents (04025)
Peptide with TGF-β antagonist properties (01070)
Vaccine Adjuvant Platform (10084)
Single chain antibodies directed to pancreatic β cells (11021)
Chemical Entities
5-Oxo-ETE Receptor antagonists (09044)
Inflammation and lipid imbalance in Cystic Fibrosis and its sequelae (06031)
Hippuristanol and derivatives as Adjuvants in Chemotherapy (05082)
Inhibitors of human Farnesyl Pyrophosphate Synthase (10114)
Multi-targeted kinase inhibitors that inhibit breast cancer progression (08082)
Inhibitors of aminoglycoside acetyltransferases to mitigate resistance to aminoglycoside antibiotics (05040)
Rocaglamide Derivatives as Chemotherapeutic & Chemosensitizing agents (10104)
Second generation Inhibitors of 6’-N-aminoglycoside acetyltransferasesas as chemosensitizers of aminoglycoside resistant strains (10082)
Novel topical treatment for pain (10029)
Novel treatment for neural diseases and conditions (08049)
